Paul Avillach, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Information Storage and Retrieval | 9 | 2019 | 824 | 1.580 |
Why?
|
Data Mining | 8 | 2018 | 537 | 1.160 |
Why?
|
Adverse Drug Reaction Reporting Systems | 9 | 2014 | 469 | 1.140 |
Why?
|
Databases, Factual | 19 | 2021 | 7730 | 0.940 |
Why?
|
MEDLINE | 2 | 2014 | 125 | 0.930 |
Why?
|
Medical Records Systems, Computerized | 8 | 2017 | 1204 | 0.820 |
Why?
|
Electronic Health Records | 17 | 2023 | 4463 | 0.730 |
Why?
|
International Classification of Diseases | 6 | 2020 | 867 | 0.690 |
Why?
|
Phenotype | 5 | 2021 | 16365 | 0.600 |
Why?
|
Databases, Genetic | 4 | 2021 | 1782 | 0.600 |
Why?
|
Unified Medical Language System | 7 | 2020 | 86 | 0.570 |
Why?
|
Semantics | 3 | 2010 | 584 | 0.540 |
Why?
|
Serial Publications | 1 | 2014 | 10 | 0.510 |
Why?
|
PubMed | 1 | 2014 | 123 | 0.480 |
Why?
|
Natural Language Processing | 4 | 2020 | 1040 | 0.460 |
Why?
|
Drug Interactions | 2 | 2015 | 1458 | 0.460 |
Why?
|
Journal Impact Factor | 1 | 2014 | 156 | 0.450 |
Why?
|
Universities | 1 | 2017 | 956 | 0.420 |
Why?
|
Sex Characteristics | 1 | 2022 | 2586 | 0.390 |
Why?
|
Medical Record Linkage | 1 | 2012 | 284 | 0.380 |
Why?
|
Methyltransferases | 1 | 2013 | 367 | 0.380 |
Why?
|
Vocabulary, Controlled | 3 | 2008 | 170 | 0.380 |
Why?
|
Purines | 1 | 2013 | 594 | 0.370 |
Why?
|
Medical Order Entry Systems | 1 | 2015 | 544 | 0.360 |
Why?
|
Europe | 12 | 2020 | 3339 | 0.350 |
Why?
|
Pharmacogenetics | 1 | 2013 | 676 | 0.350 |
Why?
|
France | 7 | 2017 | 517 | 0.350 |
Why?
|
Genome-Wide Association Study | 2 | 2020 | 12264 | 0.320 |
Why?
|
Information Dissemination | 4 | 2019 | 1100 | 0.320 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3598 | 0.320 |
Why?
|
Software | 5 | 2023 | 4442 | 0.320 |
Why?
|
Computational Biology | 2 | 2018 | 3523 | 0.320 |
Why?
|
Genetic Association Studies | 1 | 2017 | 2702 | 0.310 |
Why?
|
Medical Records | 5 | 2017 | 1413 | 0.310 |
Why?
|
Database Management Systems | 3 | 2017 | 270 | 0.290 |
Why?
|
Quantitative Trait Loci | 1 | 2013 | 2019 | 0.270 |
Why?
|
Genome, Human | 1 | 2018 | 4420 | 0.250 |
Why?
|
Mental Health | 2 | 2022 | 3019 | 0.250 |
Why?
|
Computer Security | 3 | 2014 | 263 | 0.230 |
Why?
|
Education, Medical, Graduate | 1 | 2015 | 2291 | 0.220 |
Why?
|
Acute Kidney Injury | 1 | 2015 | 1971 | 0.220 |
Why?
|
Medical Informatics | 3 | 2017 | 743 | 0.220 |
Why?
|
Pandemics | 4 | 2022 | 8387 | 0.200 |
Why?
|
Dementia | 3 | 2020 | 2518 | 0.190 |
Why?
|
Algorithms | 3 | 2021 | 13885 | 0.180 |
Why?
|
Internet | 5 | 2013 | 3063 | 0.180 |
Why?
|
Pregnancy Complications | 3 | 2018 | 2862 | 0.180 |
Why?
|
Humans | 61 | 2023 | 744220 | 0.180 |
Why?
|
Confidentiality | 4 | 2016 | 612 | 0.180 |
Why?
|
Suicide, Attempted | 2 | 2018 | 1221 | 0.180 |
Why?
|
Multilingualism | 1 | 2020 | 87 | 0.170 |
Why?
|
Suicidal Ideation | 2 | 2018 | 1248 | 0.170 |
Why?
|
Computer Communication Networks | 1 | 2020 | 295 | 0.160 |
Why?
|
Patient Discharge | 2 | 2008 | 3313 | 0.160 |
Why?
|
Product Surveillance, Postmarketing | 2 | 2013 | 430 | 0.160 |
Why?
|
Mental Disorders | 1 | 2017 | 6601 | 0.150 |
Why?
|
Terminology as Topic | 3 | 2010 | 1548 | 0.150 |
Why?
|
Sports | 2 | 2013 | 688 | 0.150 |
Why?
|
Labor, Induced | 1 | 2018 | 146 | 0.150 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2017 | 351 | 0.140 |
Why?
|
Patient Identification Systems | 2 | 2007 | 79 | 0.140 |
Why?
|
Rare Diseases | 1 | 2021 | 553 | 0.140 |
Why?
|
Hospitalization | 6 | 2022 | 10262 | 0.140 |
Why?
|
Obstetric Labor Complications | 1 | 2018 | 238 | 0.130 |
Why?
|
Medical Subject Headings | 2 | 2012 | 15 | 0.130 |
Why?
|
Infant, Newborn | 5 | 2022 | 25618 | 0.130 |
Why?
|
Hospitals, University | 1 | 2017 | 571 | 0.130 |
Why?
|
Infant | 6 | 2022 | 35129 | 0.130 |
Why?
|
Chromosome Disorders | 1 | 2017 | 515 | 0.120 |
Why?
|
Behavior | 1 | 2017 | 560 | 0.120 |
Why?
|
Hospital Information Systems | 1 | 2017 | 395 | 0.120 |
Why?
|
Anemia, Macrocytic | 1 | 2014 | 55 | 0.120 |
Why?
|
Child, Preschool | 6 | 2022 | 40992 | 0.120 |
Why?
|
Retinol-Binding Proteins | 1 | 2014 | 65 | 0.120 |
Why?
|
Adolescent | 13 | 2023 | 85759 | 0.110 |
Why?
|
Child | 12 | 2022 | 77679 | 0.110 |
Why?
|
Prevalence | 5 | 2022 | 15226 | 0.110 |
Why?
|
Triage | 1 | 2020 | 976 | 0.110 |
Why?
|
Female | 26 | 2022 | 380197 | 0.110 |
Why?
|
Demography | 1 | 2017 | 1656 | 0.110 |
Why?
|
Selection Bias | 1 | 2014 | 371 | 0.110 |
Why?
|
Quality of Health Care | 1 | 2008 | 4371 | 0.110 |
Why?
|
Chromosome Deletion | 1 | 2017 | 1401 | 0.110 |
Why?
|
Registries | 4 | 2018 | 8090 | 0.110 |
Why?
|
Limit of Detection | 1 | 2013 | 265 | 0.110 |
Why?
|
Odds Ratio | 3 | 2022 | 9849 | 0.110 |
Why?
|
Liver Failure, Acute | 1 | 2014 | 165 | 0.110 |
Why?
|
Reference Standards | 2 | 2013 | 1025 | 0.100 |
Why?
|
Privacy | 1 | 2014 | 239 | 0.100 |
Why?
|
Male | 21 | 2022 | 350027 | 0.100 |
Why?
|
Data Collection | 1 | 2021 | 3340 | 0.100 |
Why?
|
Netherlands | 3 | 2020 | 2170 | 0.100 |
Why?
|
Access to Information | 3 | 2014 | 320 | 0.100 |
Why?
|
Nervous System Diseases | 1 | 2021 | 1623 | 0.100 |
Why?
|
Automation | 1 | 2013 | 584 | 0.090 |
Why?
|
False Positive Reactions | 1 | 2013 | 981 | 0.090 |
Why?
|
Antirheumatic Agents | 1 | 2020 | 1339 | 0.090 |
Why?
|
Cesarean Section | 1 | 2018 | 1365 | 0.090 |
Why?
|
International Cooperation | 2 | 2014 | 1421 | 0.090 |
Why?
|
Genomics | 3 | 2020 | 5722 | 0.080 |
Why?
|
Health Services Research | 1 | 2017 | 1836 | 0.080 |
Why?
|
Out-of-Hospital Cardiac Arrest | 1 | 2013 | 339 | 0.080 |
Why?
|
Italy | 2 | 2020 | 832 | 0.080 |
Why?
|
Students | 1 | 2017 | 1654 | 0.080 |
Why?
|
Knowledge Bases | 1 | 2008 | 85 | 0.080 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5396 | 0.080 |
Why?
|
Databases, Bibliographic | 1 | 2008 | 128 | 0.080 |
Why?
|
Pregnancy Outcome | 1 | 2018 | 2796 | 0.080 |
Why?
|
Comorbidity | 1 | 2022 | 10387 | 0.070 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15538 | 0.070 |
Why?
|
Young Adult | 8 | 2023 | 56436 | 0.070 |
Why?
|
Prescription Drugs | 1 | 2013 | 595 | 0.070 |
Why?
|
Information Systems | 1 | 2008 | 410 | 0.070 |
Why?
|
Retrospective Studies | 9 | 2023 | 77426 | 0.070 |
Why?
|
Documentation | 1 | 2012 | 869 | 0.070 |
Why?
|
Benchmarking | 1 | 2012 | 1042 | 0.070 |
Why?
|
Middle Aged | 16 | 2023 | 213367 | 0.070 |
Why?
|
Myocardial Infarction | 2 | 2019 | 11728 | 0.070 |
Why?
|
Adult | 11 | 2023 | 214035 | 0.060 |
Why?
|
Death, Sudden, Cardiac | 1 | 2013 | 1541 | 0.060 |
Why?
|
Incidence | 4 | 2019 | 20945 | 0.060 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 14726 | 0.060 |
Why?
|
Cohort Studies | 4 | 2023 | 40559 | 0.060 |
Why?
|
Feasibility Studies | 1 | 2014 | 5076 | 0.060 |
Why?
|
Arthritis, Rheumatoid | 1 | 2020 | 3712 | 0.060 |
Why?
|
Hospital Administration | 1 | 2008 | 353 | 0.060 |
Why?
|
Nerve Tissue Proteins | 1 | 2017 | 4465 | 0.060 |
Why?
|
Biomedical Research | 2 | 2019 | 3311 | 0.060 |
Why?
|
Risk Factors | 7 | 2020 | 72280 | 0.060 |
Why?
|
Liver | 1 | 2019 | 7472 | 0.060 |
Why?
|
Aged | 11 | 2023 | 163253 | 0.060 |
Why?
|
Psychotic Disorders | 1 | 2018 | 3046 | 0.060 |
Why?
|
Hypertension | 2 | 2020 | 8480 | 0.050 |
Why?
|
Smoking | 1 | 2019 | 8986 | 0.050 |
Why?
|
Reproducibility of Results | 3 | 2023 | 19907 | 0.050 |
Why?
|
Age Distribution | 2 | 2018 | 2903 | 0.050 |
Why?
|
Exercise | 1 | 2017 | 5615 | 0.050 |
Why?
|
Statistics as Topic | 1 | 2007 | 2374 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2020 | 7659 | 0.050 |
Why?
|
Continuity of Patient Care | 1 | 2008 | 1049 | 0.050 |
Why?
|
Systems Integration | 2 | 2017 | 440 | 0.050 |
Why?
|
Phenylcarbamates | 1 | 2020 | 38 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2021 | 57768 | 0.050 |
Why?
|
Galantamine | 1 | 2020 | 32 | 0.050 |
Why?
|
Venous Thromboembolism | 1 | 2012 | 1670 | 0.040 |
Why?
|
Pilot Projects | 1 | 2013 | 8321 | 0.040 |
Why?
|
Indans | 1 | 2020 | 96 | 0.040 |
Why?
|
Pulmonary Embolism | 1 | 2012 | 2375 | 0.040 |
Why?
|
Diet | 1 | 2017 | 7937 | 0.040 |
Why?
|
Alzheimer Disease | 1 | 2020 | 8037 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17449 | 0.040 |
Why?
|
Ecosystem | 1 | 2023 | 474 | 0.040 |
Why?
|
Fetal Distress | 1 | 2018 | 40 | 0.040 |
Why?
|
Spain | 1 | 2019 | 465 | 0.040 |
Why?
|
Kidney | 1 | 2014 | 7183 | 0.040 |
Why?
|
Ethics Committees, Research | 1 | 2019 | 194 | 0.040 |
Why?
|
Healthcare Disparities | 1 | 2013 | 3158 | 0.040 |
Why?
|
Peer Review, Research | 1 | 2021 | 329 | 0.040 |
Why?
|
Fetal Macrosomia | 1 | 2018 | 124 | 0.040 |
Why?
|
Fetal Membranes, Premature Rupture | 1 | 2018 | 140 | 0.040 |
Why?
|
Abruptio Placentae | 1 | 2018 | 118 | 0.040 |
Why?
|
Stroke | 1 | 2019 | 9981 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2020 | 11732 | 0.040 |
Why?
|
Pregnancy | 4 | 2018 | 29142 | 0.030 |
Why?
|
Puerperal Disorders | 1 | 2018 | 275 | 0.030 |
Why?
|
Stillbirth | 1 | 2018 | 346 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2012 | 6352 | 0.030 |
Why?
|
Research Personnel | 1 | 2019 | 573 | 0.030 |
Why?
|
Postpartum Hemorrhage | 1 | 2018 | 258 | 0.030 |
Why?
|
Fetal Growth Retardation | 1 | 2018 | 570 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2019 | 712 | 0.030 |
Why?
|
Megestrol Acetate | 1 | 2013 | 18 | 0.030 |
Why?
|
Cisapride | 1 | 2013 | 22 | 0.030 |
Why?
|
Domperidone | 1 | 2013 | 23 | 0.030 |
Why?
|
Metoclopramide | 1 | 2013 | 50 | 0.030 |
Why?
|
Betamethasone | 1 | 2013 | 45 | 0.030 |
Why?
|
Defibrillators | 1 | 2013 | 37 | 0.030 |
Why?
|
Erythrocyte Indices | 1 | 2014 | 146 | 0.030 |
Why?
|
Publishing | 1 | 2021 | 833 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3527 | 0.030 |
Why?
|
Methotrexate | 1 | 2020 | 1720 | 0.030 |
Why?
|
European Union | 1 | 2014 | 158 | 0.030 |
Why?
|
Fluconazole | 1 | 2013 | 146 | 0.030 |
Why?
|
Blood Cell Count | 1 | 2014 | 402 | 0.030 |
Why?
|
Congenital Abnormalities | 1 | 2018 | 707 | 0.030 |
Why?
|
Swimming | 1 | 2013 | 206 | 0.030 |
Why?
|
Karnofsky Performance Status | 1 | 2012 | 173 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2020 | 21752 | 0.030 |
Why?
|
Azithromycin | 1 | 2013 | 196 | 0.030 |
Why?
|
Bicycling | 1 | 2013 | 176 | 0.030 |
Why?
|
Professional Practice | 1 | 2014 | 326 | 0.030 |
Why?
|
Piperidines | 1 | 2020 | 1605 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2019 | 12355 | 0.030 |
Why?
|
Life Support Care | 1 | 2013 | 228 | 0.030 |
Why?
|
Prognosis | 3 | 2021 | 29050 | 0.020 |
Why?
|
Molecular Weight | 1 | 2014 | 2255 | 0.020 |
Why?
|
Risk Assessment | 3 | 2019 | 23337 | 0.020 |
Why?
|
Language | 1 | 2020 | 1471 | 0.020 |
Why?
|
Logistic Models | 2 | 2018 | 13409 | 0.020 |
Why?
|
Reference Values | 1 | 2017 | 4982 | 0.020 |
Why?
|
Child Welfare | 1 | 2014 | 523 | 0.020 |
Why?
|
Informed Consent | 1 | 2016 | 995 | 0.020 |
Why?
|
Running | 1 | 2013 | 479 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 25043 | 0.020 |
Why?
|
Disclosure | 1 | 2014 | 736 | 0.020 |
Why?
|
Age Factors | 2 | 2017 | 18367 | 0.020 |
Why?
|
Catheterization, Central Venous | 1 | 2012 | 513 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3952 | 0.020 |
Why?
|
Fibrosis | 1 | 2014 | 2029 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39045 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3509 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2014 | 2170 | 0.020 |
Why?
|
Premature Birth | 1 | 2018 | 1721 | 0.020 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2013 | 978 | 0.020 |
Why?
|
Massachusetts | 1 | 2018 | 8663 | 0.020 |
Why?
|
Blood Pressure | 1 | 2020 | 8551 | 0.020 |
Why?
|
World Health Organization | 1 | 2011 | 1318 | 0.020 |
Why?
|
Lung | 1 | 2023 | 9852 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2018 | 5316 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2018 | 7784 | 0.010 |
Why?
|
United States | 3 | 2018 | 69867 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2013 | 2050 | 0.010 |
Why?
|
Time Factors | 2 | 2017 | 40063 | 0.010 |
Why?
|
United States Food and Drug Administration | 1 | 2011 | 1583 | 0.010 |
Why?
|
Acute Disease | 1 | 2013 | 7148 | 0.010 |
Why?
|
Prospective Studies | 2 | 2020 | 53280 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2012 | 6535 | 0.010 |
Why?
|
Disease Progression | 1 | 2018 | 13280 | 0.010 |
Why?
|
Recurrence | 1 | 2012 | 8343 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2010 | 2715 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 12742 | 0.010 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2014 | 2208 | 0.010 |
Why?
|
Survival Rate | 1 | 2013 | 12781 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12244 | 0.010 |
Why?
|
Computer Simulation | 1 | 2012 | 6196 | 0.010 |
Why?
|
Anticoagulants | 1 | 2012 | 4599 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15070 | 0.010 |
Why?
|
Models, Biological | 1 | 2012 | 9582 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 13668 | 0.010 |
Why?
|